Chemoinformaics analysis of Hypoxanthine-9-L-Arabinofuranoside
| Molecular Weight | 266.257 | nRot | 2 |
| Heavy Atom Molecular Weight | 252.145 | nRig | 16 |
| Exact Molecular Weight | 266.102 | nRing | 3 |
| Solubility: LogS | -1.57 | nHRing | 2 |
| Solubility: LogP | -1.784 | No. of Aliphatic Rings | 1 |
| Acid Count | 0 | No. of Aromatic Rings | 2 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 1 |
| Atoms Count | 33 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 19 | No. of Aromatic Carbocycles | 0 |
| nHetero | 8 | No. of Aromatic Hetero Cycles | 2 |
| nBridge Head | 0 | No. Saturated Carbocycles | 1 |
| No. of Hydrogen atom | 14 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 11 | No. of Saturated Rings | 1 |
| No. of Nitrogen atom | 4 | No. of Arom Atom | 9 |
| No. of Oxygen atom | 4 | No. of Arom Bond | 10 |
| nHA | 7 | APOL | 35.3131 |
| nHD | 4 | BPOL | 19.4729 |
| QED | 0.518 |
| Synth | 3.962 |
| Natural Product Likeliness | 1.013 |
| NR-PPAR-gamma | 0.003 |
| Lipinski | Accepted |
| Pfizer | Accepted |
| GSK | Accepted |
| Golden Triangle | Accepted |
| Pgp-inh | 0 |
| Pgp-sub | 0.96 |
| HIA | 0.932 |
| CACO-2 | -5.706 |
| MDCK | 0.00000518 |
| BBB | 0.869 |
| PPB | 0.161437 |
| VDSS | 0.642 |
| FU | 0.765927 |
| CYP1A2-inh | 0.005 |
| CYP1A2-sub | 0.832 |
| CYP2c19-inh | 0.01 |
| CYP2c19-sub | 0.101 |
| CYP2c9-inh | 0 |
| CYP2c9-sub | 0.893 |
| CYP2d6-inh | 0.002 |
| CYP2d6-sub | 0.063 |
| CYP3a4-inh | 0.017 |
| CYP3a4-sub | 0.048 |
| CL | 7.911 |
| T12 | 0.827 |
| hERG | 0.028 |
| Ames | 0.026 |
| ROA | 0.272 |
| SkinSen | 0.065 |
| Carcinogencity | 0.099 |
| EI | 0.016 |
| Respiratory | 0.223 |
| NR-Aromatase | 0.217 |
| Antiviral | Yes |
| Prediction | 0.878112 |